Amgen profits hit $5B, beat expectations
The biotech company recorded earnings per share of $7.60, well above the $7.46 expected by a survey of 27 analysts by Thomson Reuters.
Ceres files for $20M offering
The Thousand Oaks-based firm said it would like to use the proceeds from the public offering to expand its Brazilian operations, participate in collaborations and break into new markets.
Teledyne shares dip despite jump in Q4 profits
Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
Amgen enters into deals for colon cancer, IBD treatments
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
Limoneira shares sour on Q4 loss
Shares of Santa Paula-based Limoneira Co. plunged 8.1 percent in mid-afternoon trading on Monday after the company reported a fourth-quarter loss of $1.1 million, compared to a $141,000 profit a year earlier. The loss was primarily the result of lower avocado volume and revenue, the firm said.
